Education
About Us
Working with TipRanks
Follow Us
Oragenics Inc (OGEN)
:OGEN
OGEN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.03 - $75.60
Previous CloseN/A
Volume445.36K
Average Volume (3M)905.65K
Market Cap
$830.38K
Enterprise Value$4.95M
Total Cash (Recent Filing)$3.42M
Total Debt (Recent Filing)$2.55M
Price to Earnings (P/E)―
Beta2.08
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.85
Shares Outstanding715,843
10 Day Avg. Volume143,297
30 Day Avg. Volume905,648
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap5.97
Enterprise Value/Revenue1.58
Enterprise Value/Gross Profit-5.46
Enterprise Value/Ebitda-0.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Oragenics News
OGEN FAQ
What was Oragenics Inc’s price range in the past 12 months?
Oragenics Inc lowest stock price was $1.03 and its highest was $75.60 in the past 12 months.
What is Oragenics Inc’s market cap?
Oragenics Inc’s market cap is $830.38K.
When is Oragenics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Oragenics Inc’s earnings last quarter?
Currently, no data Available
Is Oragenics Inc overvalued?
According to Wall Street analysts Oragenics Inc’s price is currently Overvalued.
Does Oragenics Inc pay dividends?
Oragenics Inc does not currently pay dividends.
What is Oragenics Inc’s EPS estimate?
Oragenics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oragenics Inc have?
Oragenics Inc has 715,843 shares outstanding.
What happened to Oragenics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Oragenics Inc?
Currently, no hedge funds are holding shares in OGEN
Oragenics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Sold Shares
Worth $74.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 5.6%
Last 30 Days ▲ 5.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-96.41%
12-Months-Change
Fundamentals
Return on Equity
-748.05%
Trailing 12-Months
Asset Growth
-21.04%
Trailing 12-Months
Company Description
Oragenics Inc
Oragenics, Inc. (OGEN) is a biopharmaceutical company focused on the development of novel antibiotics and treatments for infectious diseases. The company operates primarily in the biotechnology sector, with a core emphasis on addressing antibiotic resistance and unmet medical needs through its research and development efforts. Oragenics is known for its proprietary lantibiotic platform, which is designed to create new antibiotics with unique mechanisms of action.
Oragenics (OGEN) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Ownership Overview
24.75% Insiders
6.90% Mutual Funds
0.49% Other Institutional Investors
68.31% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---